137 related articles for article (PubMed ID: 23688275)
41. Fingolimod Hydrochloride Gel for Dermatological Applications: Optimization of Formulation Strength and Effect of Colloidal Oatmeal (Aveeno®) as Penetration Enhancer.
Tamakuwala M; Stagni G
AAPS PharmSciTech; 2016 Aug; 17(4):907-14. PubMed ID: 26729522
[TBL] [Abstract][Full Text] [Related]
42. Bioequivalence Methodologies for Topical Drug Products: In Vitro and Ex Vivo Studies with a Corticosteroid and an Anti-Fungal Drug.
Leal LB; Cordery SF; Delgado-Charro MB; Bunge AL; Guy RH
Pharm Res; 2017 Apr; 34(4):730-737. PubMed ID: 28097506
[TBL] [Abstract][Full Text] [Related]
43. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment.
Kamran M; Ahad A; Aqil M; Imam SS; Sultana Y; Ali A
Int J Pharm; 2016 May; 505(1-2):147-58. PubMed ID: 27005906
[TBL] [Abstract][Full Text] [Related]
44. Colloidal nanocarriers for the enhanced cutaneous delivery of naftifine: characterization studies and in vitro and in vivo evaluations.
Erdal MS; Özhan G; Mat MC; Özsoy Y; Güngör S
Int J Nanomedicine; 2016; 11():1027-37. PubMed ID: 27042058
[TBL] [Abstract][Full Text] [Related]
45. Quality by design approach for formulation, evaluation and statistical optimization of diclofenac-loaded ethosomes via transdermal route.
Jain S; Patel N; Madan P; Lin S
Pharm Dev Technol; 2015 Jun; 20(4):473-89. PubMed ID: 24490793
[TBL] [Abstract][Full Text] [Related]
46. Comparative study on the topical and transdermal delivery of diclofenac incorporated in nano-emulsions, nano-emulgels, and a colloidal suspension.
Louw EV; Liebenberg W; Willers C; Dube A; Aucamp ME; Gerber M
Drug Deliv Transl Res; 2023 May; 13(5):1372-1389. PubMed ID: 36525200
[TBL] [Abstract][Full Text] [Related]
47. Novel nanosized formulations of two diclofenac acid polymorphs to improve topical bioavailability.
Pireddu R; Sinico C; Ennas G; Marongiu F; Muzzalupo R; Lai F; Fadda AM
Eur J Pharm Sci; 2015 Sep; 77():208-15. PubMed ID: 26116276
[TBL] [Abstract][Full Text] [Related]
48. In vitro and in vivo topical delivery studies of tretinoin-loaded ultradeformable vesicles.
Ascenso A; Salgado A; Euletério C; Praça FG; Bentley MV; Marques HC; Oliveira H; Santos C; Simões S
Eur J Pharm Biopharm; 2014 Sep; 88(1):48-55. PubMed ID: 24854884
[TBL] [Abstract][Full Text] [Related]
49. Development of novel diolein-niosomes for cutaneous delivery of tretinoin: influence of formulation and in vitro assessment.
Manca ML; Manconi M; Nacher A; Carbone C; Valenti D; Maccioni AM; Sinico C; Fadda AM
Int J Pharm; 2014 Dec; 477(1-2):176-86. PubMed ID: 25455770
[TBL] [Abstract][Full Text] [Related]
50. Microemulsions as transdermal drug delivery vehicles.
Kogan A; Garti N
Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424
[TBL] [Abstract][Full Text] [Related]
51. Development of ciclopirox olamine topical formulations: evaluation of drug release, penetration and cutaneous retention.
Pinheiro VA; Serikaku D; Baby AR; Velasco MV; Kaneko TM; Consiglieri VO
Pharm Dev Technol; 2015 Mar; 20(2):197-203. PubMed ID: 24286179
[TBL] [Abstract][Full Text] [Related]
52. Novel skin penetrating berberine oleate complex capitalizing on hydrophobic ion pairing approach.
Torky AS; Freag MS; Nasra MMA; Abdallah OY
Int J Pharm; 2018 Oct; 549(1-2):76-86. PubMed ID: 30053489
[TBL] [Abstract][Full Text] [Related]
53. Formulation optimization and in vitro skin penetration of spironolactone loaded solid lipid nanoparticles.
Kelidari HR; Saeedi M; Akbari J; Morteza-Semnani K; Gill P; Valizadeh H; Nokhodchi A
Colloids Surf B Biointerfaces; 2015 Apr; 128():473-479. PubMed ID: 25797482
[TBL] [Abstract][Full Text] [Related]
54. Prediction of concentration-time profile and its inter-individual variability following the dermal drug absorption.
Polak S; Ghobadi C; Mishra H; Ahamadi M; Patel N; Jamei M; Rostami-Hodjegan A
J Pharm Sci; 2012 Jul; 101(7):2584-95. PubMed ID: 22517028
[TBL] [Abstract][Full Text] [Related]
55. Diclofenac acid nanocrystals as an effective strategy to reduce in vivo skin inflammation by improving dermal drug bioavailability.
Pireddu R; Caddeo C; Valenti D; Marongiu F; Scano A; Ennas G; Lai F; Fadda AM; Sinico C
Colloids Surf B Biointerfaces; 2016 Jul; 143():64-70. PubMed ID: 26998867
[TBL] [Abstract][Full Text] [Related]
56. Hydroxypropyl-β-cyclodextrin grafted polyethyleneimine used as transdermal penetration enhancer of diclofenac sodium.
Yan Y; Xing J; Xu W; Zhao G; Dong K; Zhang L; Wang K
Int J Pharm; 2014 Oct; 474(1-2):182-92. PubMed ID: 25138253
[TBL] [Abstract][Full Text] [Related]
57. Design of acid-responsive polymeric nanoparticles for 7,3',4'-trihydroxyisoflavone topical administration.
Huang PH; Hu SC; Lee CW; Yeh AC; Tseng CH; Yen FL
Int J Nanomedicine; 2016; 11():1615-27. PubMed ID: 27143883
[TBL] [Abstract][Full Text] [Related]
58. Preparation, characterization and permeation studies of a nanovesicular system containing diclofenac for transdermal delivery.
Gaur PK; Purohit S; Kumar Y; Mishra S; Bhandari A
Pharm Dev Technol; 2014 Feb; 19(1):48-54. PubMed ID: 23281714
[TBL] [Abstract][Full Text] [Related]
59. Comparison of Clobetasol Propionate Generics Using Simplified In vitro Bioequivalence Method for Topical Drug Products.
Soares KCC; de Souza WC; de S Texeira L; da Cunha-Filho MSS; Gelfuso GM; Gratieri T
Curr Drug Deliv; 2018; 15(7):998-1008. PubMed ID: 29165079
[TBL] [Abstract][Full Text] [Related]
60. In vitro skin permeation of sinigrin from its phytosome complex.
Mazumder A; Dwivedi A; Fox LT; Brümmer A; du Preez JL; Gerber M; du Plessis J
J Pharm Pharmacol; 2016 Dec; 68(12):1577-1583. PubMed ID: 27696397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
